In this cohort, TMB, TNB, and the immune phenotype (IP), were available, and PD-L1 expression on tumor cells (TC) and immune cells (IC) was stained and evaluated as IC0/TC0 (< 1%), IC1/TC1 (≥ 1% and < 5%), or IC2/TC2 (≥ 5%). This evidence concerns the gene CD274 and neoplasm.